Cargando…
The systemic inhibition of the terminal complement system reduces neuroinflammation but does not improve motor function in mouse models of CMT1A with overexpressed PMP22
Charcot-Marie-Tooth disease type 1A (CMT1A) is the most prevalent hereditary demyelinating neuropathy. This autosomal, dominantly inherited disease is caused by a duplication on chromosome 17p which includes the peripheral myelin protein 22 (PMP22) gene. There is clinical evidence that the disabilit...
Autores principales: | Michailidou, Iliana, Vreijling, Jeroen, Rumpf, Matthijs, Loos, Maarten, Koopmans, Bastijn, Vlek, Nina, Straat, Nina, Agaser, Cedrick, Kuipers, Thomas B., Mei, Hailiang, Baas, Frank, Fluiter, Kees |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011818/ https://www.ncbi.nlm.nih.gov/pubmed/36926597 http://dx.doi.org/10.1016/j.crneur.2023.100077 |
Ejemplares similares
-
Editorial: Complement in nervous system disease
por: Michailidou, Iliana, et al.
Publicado: (2023) -
PMP22 exon 4 deletion causes ER retention of PMP22 and a gain‐of‐function allele in CMT1E
por: Wang, David S., et al.
Publicado: (2017) -
Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis
por: Michailidou, Iliana, et al.
Publicado: (2018) -
Development, Characterization, and in vivo Validation of a Humanized C6 Monoclonal Antibody that Inhibits the Membrane Attack Complex
por: Gytz Olesen, Heidi, et al.
Publicado: (2022) -
A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice
por: Stavrou, Marina, et al.
Publicado: (2022)